IFNG-producing self-reactive CD4+ T cells drive autoimmune adrenalitis in a mouse model of Addison's disease

Abstract

Autoimmune Addisons disease (AD) is a rare but life-threatening disorder caused by immune-mediated destruction of the adrenal cortex, and progress in therapy has been limited by insufficient mechanistic insight. Here, we establish a model of Experimental Autoimmune Adrenalitis (EAA) that recapitulates key features of AD and reveals sex-dependent differences in disease manifestation within the model. Immunization with peptides derived from the adrenal self-antigen CYP11A1 induces corticosterone insufficiency. We show that autoimmune adrenalitis is driven by IFNG produced by self-reactive CD4 T cells, promoting granulomatous inflammation in the adrenal cortex. Together, these findings identify IFNG as a central effector of autoimmune adrenalitis and suggest that targeting the IFNG pathway may represent a potential therapeutic strategy for AD. SignificanceAddisons disease (AD) is a rare autoimmune disorder that destroys the adrenal cortex, yet its underlying mechanisms remain unknown. We developed a mouse model of Experimental Autoimmune Adrenalitis (EAA) that mirrors the hormonal and immunological features of AD. Our study reveals that IFNG-producing CD4 T cells drive adrenal inflammation and dysfunction, identifying IFNG as a key pathogenic factor and a potential therapeutic target.